Page last updated: 2024-11-13

rebaudioside d

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

rebaudioside D: isolated from Stevia rebaudiana [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

rebaudioside D : A rebaudioside that is rebaudioside A in which the hydroxy group at position 2 of the beta-D-glucosyl ester moiety has been converted to the corresponding beta-D-glucoside. Found in minute quantities in the leaves of Stevia rebaudiana. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
SteviagenusA plant genus of the family ASTERACEAE. Members contain stevioside and other sweet diterpene glycosides. The leaf is used for sweetening (SWEETENING AGENTS).[MeSH]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]
Stevia rebaudianaspecies[no description available]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]

Cross-References

ID SourceID
PubMed CID71773169
CHEMBL ID3286747
CHEBI ID145022
MeSH IDM0592167

Synonyms (32)

Synonym
2-o-beta-d-glucopyranosyl-1-o-(13alpha-{[beta-d-glucopyranosyl-(1->2)-[beta-d-glucopyranosyl-(1->3)]-beta-d-glucopyranosyl]oxy}-18-oxo-5beta,8alpha,9beta,10alpha-kaur-16-en-18-yl)-beta-d-glucopyranose
rebaudioside d
(-)-rebaudioside d
reb-d
reb d
rebaudioside-d
CHEBI:145022 ,
63279-13-0
S3259
unii-1su114wxbx
1su114wxbx ,
kaur-16-en-18-oic acid, 13-((o-beta-d-glucopyranosyl-(1->2)-o-(beta-d-glucopyranosyl-(1->3))-beta-d-glucopyranosyl)oxy)-, 2-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl ester, (4alpha)-
rebaudioside d, (-)-
CHEMBL3286747
kaur-16-en-18-oic acid, 13-((o-.beta.-d-glucopyranosyl-(1->2)-o-(.beta.-d-glucopyranosyl-(1->3))-.beta.-d-glucopyranosyl)oxy)-, 2-o-.beta.-d-glucopyranosyl-.beta.-d-glucopyranosyl ester, (4.alpha.)-
fema no. 4921
rebaudioside d [mi]
rebd
AC-34450
2-o-beta-d-glucopyranosyl-1-o-(13alpha-((beta-d-glucopyranosyl-(1->2)-(beta-d-glucopyranosyl-(1->3))-beta-d-glucopyranosyl)oxy)-18-oxo-5beta,8alpha,9beta,10alpha-kaur-16-en-18-yl)-beta-d-glucopyranose
dtxcid101477730
RPYRMTHVSUWHSV-CUZJHZIBSA-N
HY-N0468
DTXSID601019860 ,
Q27252844
CS-0008993
D85011
MS-31994
(4r)-13-[[2-o-(beta-d-glucopyranosyl)-3-o-(beta-d-glucopyranosyl)-beta-d-glucopyranosyl]oxy]kaur-16-en-18-oic acid 2-o-(beta-d-glucopyranosyl)-beta-d-glucopyranosyl ester
JDO ,
kaur-16-en-18-oic acid, 13-[(o-?-d-glucopyranosyl-(1?2)-o-[?-d-glucopyranosyl-(1?3)]-?-d-glucopyranosyl)oxy]-, 2-o-?-d-glucopyranosyl-?-d-glucopyranosyl ester, (4?)-; rebaudioside d
AKOS040750454

Research Excerpts

Overview

Rebaudioside D is a sweetener from Stevia rebaudiana with superior sweetness and organoleptic properties. Its production is limited by its minute abundance in S.rebaudiana leaves.

ExcerptReferenceRelevance
"Rebaudioside D is a sweetener from Stevia rebaudiana with superior sweetness and organoleptic properties, but its production is limited by its minute abundance in S. rebaudiana leaves. "( Production of rebaudioside D from stevioside using a UGTSL2 Asn358Phe mutant in a multi-enzyme system.
Cai, R; Chen, K; Chen, L; Jia, H; Li, Y; Ouyang, P; Weng, J; Yan, M, 2020
)
2.36
"Rebaudioside D is a promising sweetener due to its zero calorie and high sweetness. "( Heterologous expression of EUGT11 from Oryza sativa in Pichia pastoris for highly efficient one-pot production of rebaudioside D from rebaudioside A.
Hong, J; Huang, T; Liu, W; Liu, Z; Ma, S; Ma, Y; Song, H; Wang, Z, 2020
)
2.21
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
sweetening agentSubstance that sweeten food, beverages, medications, etc.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
tetracyclic diterpenoidA diterpenoid with a tetracyclic skeleton.
rebaudiosideAny of the steviol glycosides found in the leaves of the stevia plant, Stevia rebaudiana. They are typically more than 100 times sweeter than sucrose.
sophorosideAny glycoside of sophorose (2-O-beta-D-glucopyranosyl-D-glucopyranose).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1151323Antimicrobial activity against Pseudomonas aeruginosa ATCC 278532014Journal of natural products, May-23, Volume: 77, Issue:5
Minor diterpene glycosides from the leaves of Stevia rebaudiana.
AID1151322Antimicrobial activity against Escherichia coli ATCC 352182014Journal of natural products, May-23, Volume: 77, Issue:5
Minor diterpene glycosides from the leaves of Stevia rebaudiana.
AID1151320Antimicrobial activity against Aspergillus fumigatus ATCC 909062014Journal of natural products, May-23, Volume: 77, Issue:5
Minor diterpene glycosides from the leaves of Stevia rebaudiana.
AID1151321Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 433002014Journal of natural products, May-23, Volume: 77, Issue:5
Minor diterpene glycosides from the leaves of Stevia rebaudiana.
AID1151324Antimicrobial activity against Mycobacterium intracellulare ATCC 230682014Journal of natural products, May-23, Volume: 77, Issue:5
Minor diterpene glycosides from the leaves of Stevia rebaudiana.
AID1151318Antimicrobial activity against Candida albicans ATCC 900282014Journal of natural products, May-23, Volume: 77, Issue:5
Minor diterpene glycosides from the leaves of Stevia rebaudiana.
AID1151319Antimicrobial activity against Cryptococcus neoformans ATCC 901132014Journal of natural products, May-23, Volume: 77, Issue:5
Minor diterpene glycosides from the leaves of Stevia rebaudiana.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (75.00)24.3611
2020's3 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.91 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index47.16 (26.88)
Search Engine Supply Index2.36 (0.95)

This Compound (33.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]